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Abstract
We present a rare case of a facial nerve granular cell tumour in the right parotid gland, in a 10-year-old boy. A parotid or
neurogenic tumour was suspected, based on magnetic resonance imaging. Intra-operatively, strong adhesions to
surrounding structures were found, and a midfacial nerve branch had to be sacrificed for complete tumour removal.
Recent reports verify that granular cell tumours arise from Schwann cells of peripheral nerve branches. The rarity of
this tumour within the parotid gland, its origin from peripheral nerves, its sometimes misleading imaging
characteristics, and its rare presentation with facial weakness and pain all have considerable implications on the
surgical strategy and pre-operative counselling. Fine needle aspiration cytology may confirm the neurogenic origin of
this lesion. When resecting the tumour, the surgeon must anticipate strong adherence to the facial nerve and be
prepared to graft, or sacrifice, certain branches of this nerve.
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Introduction
Granular cell tumours were first described in the literature in
1926 by Abrikossoff, who presented five cases of rhabdo-
myoma in the head and neck region.1 However, the first
case of a granular cell tumour, occurring in the tongue of a
21-year-old man, was probably published in 1854 by
Weber.2 This tumour was initially thought to derive from
muscle cells, but recent immunohistological investigations
have confirmed a neural origin. Since S-100 and cluster of
differentiation 68 glycoprotein staining have become avail-
able, a Schwann cell derivation has been strongly
suggested.3–8 In 1983, May et al. described the first granular
cell tumour of the facial nerve, located in the mastoid.9
Less than 20 cases of granular cell tumours of the parotid
have previously been published, and this tumour is hardly
ever mentioned in the differential diagnosis of parotid or
facial nerve tumours. We present an additional case and
review previous case reports, including the relation of these
tumours to the facial nerve, their clinical presentation and
the value of fine needle aspiration cytology (FNAC) in the
pre-operative setting.
Case report
This case report was approved by the institutional review
board of Kantonale Ethikkommission Luzern.
A 10-year-old boy was referred to our out-patient clinic
with a two-year history of a firm, painless tumour at the
anterior border of the right parotid gland. Facial nerve func-
tion was normal, and the tumour could easily be palpated as a
solid mass with a smooth surface between the parotid gland
and the masseter muscle.
On magnetic resonance imaging, a 16 × 15 × 10 mm, neu-
rogenic tumour was suspected. However, due to the tumour’s
close relationship with the masseter muscle, a rhabdomyo-
sarcoma or low-grade parotid carcinoma could not be com-
pletely excluded (Figure 1).
Surgical removal was recommended. Antibody directed
against epitopes of several cytokeratins (cytokeratins 5, 6,
8, 17, 19; “pan-cytokeratin”-marker). A face-lift incision
was performed, and the tumour was located at the anterior
rim of the superficial parotid gland. The peripheral facial
nerve branches were identified, the parotid capsula opened,
and a firm mass was dissected out from the parotid gland
and the masseter muscle. The muscle fibres were tightly
attached to the tumour capsule. One midfacial, small, periph-
eral branch of the facial nerve was dissected under the oper-
ating microscope, but disappeared into the tumour capsule
and could not be preserved. The tumour was removed com-
pletely. The patient’s facial function remained unchanged,
even to the experienced observer.
Histological examination of the resected mass (Figure 2)
revealed an unencapsulated, diffusely demarcated, epithe-
lioid tumour, with distinct infiltration of a markedly fibrous
stroma as well as of the resected striated muscle tissue. The
tumour cells showed quite uniformly shaped, round to oval
nuclei. No mitoses were observed. The cell borders were
overall rather poorly defined, and there was abundant cyto-
plasm containing fine granules that appeared eosinophilic
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with standard haematoxylin and eosin staining. These gran-
ules stained positive in an additional periodic acid Schiff
colouration.
Additional immunohistochemical staining revealed strong
positivity of the tumour cells for S-100 and neuron-specific
enolase, but complete negativity when stained for the pan-
cytokeratin marker MNF116 antibody directed against epi-
topes of several cytokeratins (cytokeratins 5, 6, 8, 17, 19;
“pan-cytokeratin”-marker). Staining for Ki-67 (nuclear
protein associated with cellular proliferation) showed a low
proliferation index of approximately 1–2 per cent.
Histological findings indicated the classic histomorphol-
ogy of a granular cell tumour, confirmed by immunohisto-
chemical analysis.
A large-calibre branch of a peripheral nerve in close proxi-
mity to the tumour could be demonstrated on serial sections.
However, clear-cut transition of this nerve into the granular
cell tumour was not evident.
Discussion
Since the first descriptions by Weber and Abrikosoff, many
more than 1200 cases of granular cell tumour have been
described, as reported by McDaniel and
Apisarntarax.1,2,10,11 Granular cell tumours were originally
thought to be derived from skeletal muscle cells, but nerve
sheath differentiation was proposed by Feyter in 1935, and
Schwann cell origin was described by Fischer and
Wechsler in 1962.1,11–13
Histologically, granular cell tumours represent 0.017–0.029
per cent of all surgical specimens. They are usually (70 per
cent) situated in the subcutaneous layers of the skin or head
and neck region, but no organ seems to be immune to their
development. Of granular cell tumours identified in the head
and neck, 30 per cent are located in the tongue.12,14,15 There
is a clear female predominance (two:one) and a greater preva-
lence in Afro-Americans than Caucasians.6,8,10–12,14–16 In 8 to
16 per cent of patients, multiple lesions are present.6,11,14 The
tumour is mainly found in adults; however, we present the
second case of a parotid granular cell tumour presenting in a
child.
Benign granular cell tumours of the parotid usually present
as slow-growing masses which rarely reach more than 3 cm
in size. Pain, discolouration of the skin and even facial
paresis may sometimes accompany this lesion. Granular
cell tumours may infiltrate the gland parenchyma, and a
close association with peripheral facial nerve fibres is often
noted. Often, a malignant lesion of the parotid is suspected
based on imaging and a clinical presentation of facial
paresis or pain. Therefore, FNAC should be included in the
diagnostic assessment of any parotid lesion. This investi-
gation can help to differentiate between benign and malig-
nant lesions, and to counter the initial suspicion of a
malignant lesion (based on imaging). On reviewing the lit-
erature (Table I), of the 17 cases of parotid gland granular
cell tumour previously described, a malignant diagnosis
could often not be excluded. Fine needle aspiration
cytology was performed in only five of the total 18 reported
cases; this showed the benign origin of the lesion in all five
cases. Facial nerve involvement was clearly present in six
cases upon surgery, but only one patient showed pre-operat-
ive facial palsy. In most of these six cases, peripheral
branches had to be sacrificed, and in the patient with
pre-operative palsy a cable graft was even necessary due
to the large extension of the lesion in relation to the
facial nerve.6,7,10–12,14,17–26
Although malignant forms of granular cell tumours are
described, they seem to be extremely rare: of all reported
granular cell tumours, less than 2–3 per cent were malig-
nant.6,10,11 A malignant variant must be suspected in a
patient with a clinical history of rapid tumour growth,
tumour size over 3 cm and metastasis (as reported in one
case), together with suspicious histological features such as
mitotic figures, cellular and nuclear pleomorphism, necrosis,
and a high Ki-67 proliferation index.3 Malignant forms are
usually found on the extremities and have a high mortality
rate, with 40–60 per cent survival rate over three
years.6,11,12,21,27
• Granular cell tumours are of Schwann cell origin
• Although more frequently found within the
tongue, they may also arise along facial nerve
branches within the parotid gland
• Fine needle aspiration of the firm mass has a high
probability of leading to the correct diagnosis
Since the introduction of immunohistochemical staining, the
histogenetic link between Schwann cells and granular cell
tumours has been clearly demonstrated, based on addition-
ally observed ultrastructural features and positive reactions
for neural markers such as S-100 calcium-binding protein
present in various tissues protein, PGP 9.5, Member of
ubiquitine hydrolase protein family, present in neural
tissues, but also detected in various mesenchymal tissues
α-inhibin, and histocytic markers such as cluster of differen-
tiation 68 glycoprotein (also known as KP-1 (CD68, also
FIG. 1
Axial magnetic resonance imaging scan showing a 16 × 15 × 10 mm
nodule situated between the superficial parotid lobe and the mass-
eter muscle. T1 and T2 sequences revealed an inhomogeneous,
moderately hypodense mass with homogeneous contrast
enhancement (+).
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known as KP-1) KP-1: Synonym of CD68, a transmembrane
lysosome associated protein located in macrophages and
other cells of the macrophage/monocyte-lineage) and vimen-
tin.4,5,12,24 It is important to realise that granular cell
tumours, although of Schwann cell origin, are not histologi-
cally identical to schwannomas, but rather constitute an
entity of their own. Classically, schwannomas are encapsu-
lated tumours of spindle-shaped cells that are typically
arranged in a biphasic pattern composed of hypocellular
Antoni B areas and cellular Antoni A areas containing
Verocay bodies and showing pronounced nuclear palisading.
In contrast, granular cell tumours are usually non-encapsu-
lated and show more epithelioid than spindle cell mor-
phology. Both entities stain positive for S-100, but
schwannomas sometimes express glial fibrillary acidic
protein, which can be helpful in distinguishing the two
during immunocytochemical analysis of FNAC specimens.28
In keeping with the known derivation of granular cell
tumours from Schwann cells, these tumours can originate
from any peripheral nerve sheath, and tight adherence to
facial nerve branches is not uncommon. In at least six of
the 18 reported cases of parotid granular cell tumour, such
interference with the facial nerve was described. Therefore,
granular cell tumours of the parotid can be facial nerve
tumours.9,19–23 In the diagnostic investigation of a firm
parotid lesion, one must realise that a granular cell tumour
may be found within the parotid along facial nerve branches.
Fine needle aspiration cytology can differentiate a neuro-
genic tumour from other tumours of the parotid and thus
guide the surgeon. If a neurogenic lesion is found, FNAC
can also differentiate a schwannoma from a granular cell
tumour, with the help of immunocytochemical
analysis.4,5,12,24,28
Various decision-making algorithms have been described
for the treatment of facial nerve schwannoma. In general, a
‘watch and wait’ attitude is adopted if there are no signs of
facial palsy.29 However, in the case of granular cell
tumour, resection is advised due to this tumour’s tendency
to grow and minor risk of malignancy. Treatment must be
discussed with the patient, including the risk that, if strong
adherence to the facial nerve is found, small peripheral
branches may need to be sacrificed. The patient should
also be aware that, in the case of larger facial nerve involve-
ment, grafting may be required, with (temporary) palsy as a
consequence. Tumour origin from other nerves within the
parotid (secretory or sensory) can only be verified at surgery.
At surgery, the lesion is usually apparent as a hard, yellow-
ish nodule in a distal region of the parotid gland.6,7,10,11 Total
FIG. 2
(a) Photomicrograph showing cells of a granular cell tumour infiltrating fibrous stroma (H&E; ×200). (b) Photomicrograph showing granular
cell tumour cells staining positively for S-100 (×200); adjacent, S-100-negative striated muscle cells (asterisk) serve as an internal negative
control. (c) Photomicrograph of tumour periphery showing infiltration of surrounding fibrous and fatty tissue, together with an adjacent
branch of a large calibre nerve (arrow) (H&E; ×25).
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TABLE I
PAROTID GLAND GRANULAR CELL TUMOUR: REPORTED CASES
Study Age (y) Sex Complaint Imaging FNAC Size
(cm)
Site Surgery VII involved?
de Sequeira et al.17 31 F Mass None None 0.7 Multiple Node picking No
Nussbaum & Haselkorn18 36 M Mass None None 2.5 Single Hockeystick No
Seifert et al.19 6 F Mass None None 2.0 Single NS Yes
Nielsen et al.20 51 F Mass None Benign 1.5 Single Total parotidectomy Yes
Lack et al.14 NS NS NS NS NS 1.0 Single NS NS
Apisarnthanarax11 52 F Mass NS NS 1.5 Single NS NS
Mullins & Wagner3 60 F Mass None None NS Metastasis NS No
McDaniel10, case 1 NS NS NS NS NS NS Single NS NS
McDaniel10, case 2 NS NS NS NS NS NS Single NS NS
Curtis et al.6 37 F Mass MRI Benign 2.0 Multiple Sup parotidectomy NS
Carinci et al.21 30 F Mass, pain CT Benign 2.0 Single Parotidectomy Yes
Said Al Naief et al.22 49 F VII palsy, pain CT, MRI None 3.0 Single Sup parotidectomy Yes, cable graft
Smith et al.23 48 F Mass MRI None 1.5 Single Total parotidectomy Temp palsy post-op
Chae et al.24 46 F Mass CT Benign 1.0 Single Sup parotidectomy NS
Bonfils et al.7 55 F Mass MRI Benign∗ 3.0 Single Enucleation No
Dismosthenous et al.25 47 F Mass NS None 3.0 Single NS NS
Bomfin et al.26 58 F Mass NS None 3.0 Multiple Sup parotidectomy NS
Present 10 M Mass MRI None 1.6 Single Sup parotidectomy Yes
Total† Mean 41 13 F 2 M 15 mass 2 pain 1 VII palsy 5 MRI 3 CT 5 of 18 All benign Mean 1.95 14 single 3 multiple 6 of 18
∗Schwannoma. †18 cases. Y= years; FNAC= fine needle aspiration cytology; VII= facial nerve; F= female; M=male; NS= not stated; MRI=magnetic resonance imaging; sup= superficial; CT= com-
puted tomography; post-op= post-operatively
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removal with margins is advised as recurrence is found in
5–15 per cent, probably due to incomplete removal.10,14,16
Radiotherapy and chemotherapy appear to be of no value
for granular cell tumour treatment, in the peri-operative
setting.6,7,10,11,14,17-26
Conclusion
Current textbooks do not mention granular cell tumour
within the differential diagnosis of parotid lesions or facial
nerve tumours. Even though parotid granular cell tumours
are benign lesions, they often mimic facial nerve tumours
and thus must be treated accordingly. The patient must be
informed of the higher risk of post-operative facial palsy,
compared with ‘normal’ parotid surgery for other benign
lesions. Pathologists must be aware of this lesion, and
should confirm their identification using appropriate immu-
nohistochemical staining. The surgeon should be aware
that even a benign lesion can present with facial weakness,
pain and skin discolouration. Fine needle aspiration cytology
will assist decision-making and patient counselling. The
surgeon should also anticipate strong adherence to the
facial nerve and surrounding tissue during superficial paroti-
dectomy, and should be ready to sacrifice and graft any per-
ipheral branch of the facial nerve if necessary.
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